Cryoport (CYRX) Competitors

Cryoport logo
$6.70 -0.05 (-0.74%)
Closing price 02/13/2025 04:00 PM Eastern
Extended Trading
$6.87 +0.17 (+2.60%)
As of 02/13/2025 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CYRX vs. NRIX, DYN, VIR, KNSA, ARDX, MRVI, XNCR, SNDX, DAWN, and ANIP

Should you be buying Cryoport stock or one of its competitors? The main competitors of Cryoport include Nurix Therapeutics (NRIX), Dyne Therapeutics (DYN), Vir Biotechnology (VIR), Kiniksa Pharmaceuticals (KNSA), Ardelyx (ARDX), Maravai LifeSciences (MRVI), Xencor (XNCR), Syndax Pharmaceuticals (SNDX), Day One Biopharmaceuticals (DAWN), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry.

Cryoport vs.

Nurix Therapeutics (NASDAQ:NRIX) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment, earnings and community ranking.

92.9% of Cryoport shares are owned by institutional investors. 7.2% of Nurix Therapeutics shares are owned by company insiders. Comparatively, 10.1% of Cryoport shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cryoport has higher revenue and earnings than Nurix Therapeutics. Nurix Therapeutics is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nurix Therapeutics$54.55M24.44-$193.57M-$2.89-6.08
Cryoport$233.26M1.42-$99.59M-$3.38-1.98

Cryoport received 162 more outperform votes than Nurix Therapeutics when rated by MarketBeat users. However, 79.41% of users gave Nurix Therapeutics an outperform vote while only 65.15% of users gave Cryoport an outperform vote.

CompanyUnderperformOutperform
Nurix TherapeuticsOutperform Votes
81
79.41%
Underperform Votes
21
20.59%
CryoportOutperform Votes
243
65.15%
Underperform Votes
130
34.85%

In the previous week, Nurix Therapeutics had 2 more articles in the media than Cryoport. MarketBeat recorded 2 mentions for Nurix Therapeutics and 0 mentions for Cryoport. Nurix Therapeutics' average media sentiment score of 0.92 beat Cryoport's score of 0.00 indicating that Nurix Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Nurix Therapeutics Positive
Cryoport Neutral

Nurix Therapeutics has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500.

Cryoport has a net margin of -70.08% compared to Nurix Therapeutics' net margin of -354.85%. Cryoport's return on equity of -13.35% beat Nurix Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Nurix Therapeutics-354.85% -53.65% -38.59%
Cryoport -70.08%-13.35%-6.43%

Nurix Therapeutics presently has a consensus target price of $31.12, indicating a potential upside of 77.11%. Cryoport has a consensus target price of $12.29, indicating a potential upside of 83.37%. Given Cryoport's higher probable upside, analysts clearly believe Cryoport is more favorable than Nurix Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nurix Therapeutics
0 Sell rating(s)
1 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.94
Cryoport
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

Summary

Cryoport beats Nurix Therapeutics on 10 of the 18 factors compared between the two stocks.

Get Cryoport News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYRX vs. The Competition

MetricCryoportPharmaceutical IndustryTransportation SectorNASDAQ Exchange
Market Cap$331.18M$6.93B$306.74B$9.18B
Dividend YieldN/A2.90%4.36%4.00%
P/E Ratio-1.989.8516.7619.43
Price / Sales1.42289.0659.0777.19
Price / Cash17.9275.4612.7238.87
Price / Book0.715.572.105.07
Net Income-$99.59M$123.72M$583.39M$222.90M
7 Day Performance-4.42%-2.08%-0.54%0.37%
1 Month Performance-20.14%1.11%-0.06%5.51%
1 Year Performance-55.03%5.75%6.10%23.18%

Cryoport Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYRX
Cryoport
2.321 of 5 stars
$6.70
-0.7%
$12.29
+83.4%
-55.0%$331.18M$233.26M-1.981,170
NRIX
Nurix Therapeutics
2.313 of 5 stars
$18.78
-4.7%
$31.12
+65.7%
+101.5%$1.44B$54.55M-6.59300
DYN
Dyne Therapeutics
3.5318 of 5 stars
$13.93
-2.0%
$49.91
+258.2%
-39.2%$1.43BN/A-3.94100
VIR
Vir Biotechnology
4.2139 of 5 stars
$9.97
-4.1%
$34.83
+249.4%
+8.2%$1.37B$86.18M-2.54580
KNSA
Kiniksa Pharmaceuticals
3.5479 of 5 stars
$19.00
-3.1%
$36.60
+92.6%
-1.1%$1.36B$270.26M-134.91220Insider Trade
News Coverage
ARDX
Ardelyx
3.4561 of 5 stars
$5.32
-0.8%
$9.42
+77.2%
-36.1%$1.26B$124.46M-17.7590Upcoming Earnings
Short Interest ↑
Gap Down
MRVI
Maravai LifeSciences
4.2613 of 5 stars
$4.96
+0.5%
$10.28
+107.5%
-19.8%$1.25B$288.95M-3.02610
XNCR
Xencor
3.8636 of 5 stars
$17.71
-3.1%
$34.88
+96.9%
-14.8%$1.24B$168.34M-5.56280
SNDX
Syndax Pharmaceuticals
3.8204 of 5 stars
$14.43
+1.8%
$36.20
+150.9%
-28.9%$1.24BN/A-3.99110Insider Trade
DAWN
Day One Biopharmaceuticals
1.8191 of 5 stars
$12.09
-2.3%
$35.86
+196.6%
-14.0%$1.22BN/A-11.7760
ANIP
ANI Pharmaceuticals
4.3884 of 5 stars
$58.02
-1.1%
$77.71
+34.0%
+7.6%$1.22B$486.82M-105.49600

Related Companies and Tools


This page (NASDAQ:CYRX) was last updated on 2/14/2025 by MarketBeat.com Staff
From Our Partners